Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed PhD and NHMRC Fellow Patrick Hughes as R&D Manager Immunobiology.
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma clients conducting preclinical and clinical trials in Asia, US, EU and Australia.
Australia-based Agilex Biolabs announced a broad range of new pharmacodynamics services for biopharma clients running preclinical and clinical trials in the U.S., Asia, European Union and Australia.
...
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory based in Australia, announced a raft of new pharmacodynamics services for biotech and pharma clients conducting preclinical and clinical trials in Asia, US, EU and Australia.
One of the most important drug development start-up decisions is finding a centrally located bioanalytical laboratory that can support clinical research across all the study locations, and through pre-clinical then potentially for all Phases.
Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Quality control and consistency of sample management and analysis from early Phase onwards can make a real difference to quality of data and final outcomes.
Australia-based Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for global clients conducting preclinical and clinical trials, announced at AusBiotech 2019 today it has been selected as a Top 10 Bioanalytical Services Provider by PharmaTech Outlook Magazine (Booth #523).
Boston, MA – Agilex Biolabs, the Asia Pacific’s leading bioanalytical laboratory, announced at “OCT New England”...
...
